1999 - Founded
Minerva Analytix GmbH (German equivalent of an Inc.) was founded in 1999 as part of Minerva Biolabs GmbH by Dr. Dirk Vollenbroich. Analytic services were part of the company right from the beginning.
2014 - Spin-Off from Minerva Biolabs
As a result of continuing growth in a GMP regulated environment the two divisions Minerva Analytix GmbH and Minerva Biolabs GmbH were separated in 2014. While Minerva Biolabs GmbH continues to produce high quality products in the field of contamination safety, Minerva Anlytix GmbH now has its own facilities and thus fulfills an important criterion for GMP-compliant test laboratories.
2017 - GMP Re-Certification
With the 2017 re-certification we have successfully finished rebuilding the quality management system according to EU-GMP and cGMP guidelines and extended the scope of our testing by endotoxin testing.
2018 - Permits
Our BSL-2/3 **, Genetic Engineering S2 and Infection Protection permits have been renewed.
2019 - Service Portfolio Extended
We have successfully introduced an innovative nucleic acid-based sterility test for R&D and In-process testing and are preparing to implement as GMP testing service for LOT release. Sterility testing in 24-48 hours!
2019 - New Facilities
Our new facilities are finished – all required inspections (GMP, Biosafety, Work Safety and Genetic Engineering) have been positively been renewed. We are ready to start at our new Rangsdorf site close to Berlin and are looking forward to working with you.
2020 - Facilities Expansion
We are happy to grow together with our customers and are able to move into a renovated new floor with office space. Despite the difficult situation in the Covid-19 year, we continue to be available for our GMP customers and plan to expand our service capacity in the field of rapid microbial testing by nucleic acid amplification.